Profound Hypogammaglobulinemia 7 Years after Treatment for Indolent Lymphoma

By Walker Alison   Kleiner Anatole   Rich Lynn   Conners Charlene   Fisher Richard   Anolik Jennifer   Friedberg Jonathan  

Cancer Investigation, Vol. 26, Iss. 4, 2008-05 ,pp. : 431-433

Informa Healthcare

Access to resources Recommend Favorite

Symptomatic BK virus reactivation following fludarabine, cyclophosphamide and rituximab chemotherapy for chronic lymphocytic leukemia/small lymphocytic lymphoma

By Appleby Niamh   Dillon Anna   Arrigan Martin   Fennell Jerome   Crowley Brendan   Hayden Patrick J.   Enright Helen  

Leukemia and Lymphoma, Vol. 55, Iss. 5, 2014-05 ,pp. : 1181-1183

Informa Healthcare

Access to resources Recommend Favorite

Effects of addition of rituximab to chemotherapy on central nervous system events in patients with diffuse large Bcell lymphoma

By              

Molecular and Clinical Oncology, Vol. 3, Iss. 4, 2015-01 ,pp. : 747-752

Science Publishers

Access to resources Recommend Favorite

Dexamethasone, High-Dose Cytarabine, and Cisplatin in Combination with Rituximab as Salvage Treatment for Patients with Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

By Mey Ulrich   Orlopp Katjana   Flieger Dimitri   Strehl John   Ho Anthony   Hensel Manfred   Bopp Cordula   Gorschlüter Marcus   Wilhelm Martin   Birkmann Josef   Kaiser Ulrich   Neubauer Andreas   Florschütz Axel   Rabe Christian   Hahn Corinna   Glasmacher Axel   Schmidt-Wolf Ingo  

Cancer Investigation, Vol. 24, Iss. 6, 2006-09 ,pp. : 593-600

Informa Healthcare

Access to resources Recommend Favorite

GuillainBarré syndrome and severe infection following chemotherapy for peripheral Tcell lymphoma: A case report

By  

Oncology Letters, Vol. 8, Iss. 6, 2014-01 ,pp. : 2695-2698

Spandidos Publications

Access to resources Recommend Favorite